Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immucell (ICCC) Profit After Tax (2016 - 2025)

Immucell's Profit After Tax history spans 16 years, with the latest figure at -$2.8 million for Q4 2025.

  • For Q4 2025, Profit After Tax fell 653.71% year-over-year to -$2.8 million; the TTM value through Dec 2025 reached -$1.0 million, up 51.78%, while the annual FY2025 figure was -$1.0 million, 51.78% up from the prior year.
  • Profit After Tax reached -$2.8 million in Q4 2025 per ICCC's latest filing, down from -$139748.0 in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $1.4 million in Q1 2025 to a low of -$2.8 million in Q4 2025.
  • Average Profit After Tax over 5 years is -$577167.6, with a median of -$548190.5 recorded in 2021.
  • Peak YoY movement for Profit After Tax: crashed 2349.8% in 2022, then skyrocketed 430.46% in 2025.
  • A 5-year view of Profit After Tax shows it stood at $74134.0 in 2021, then plummeted by 2349.8% to -$1.7 million in 2022, then surged by 31.66% to -$1.1 million in 2023, then skyrocketed by 145.14% to $514555.0 in 2024, then plummeted by 653.71% to -$2.8 million in 2025.
  • Per Business Quant, the three most recent readings for ICCC's Profit After Tax are -$2.8 million (Q4 2025), -$139748.0 (Q3 2025), and $501880.0 (Q2 2025).